(Q73327949)

English

Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki Sieb

scientific article published on 01 April 1997

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki Sieb (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Broussonetia kazinoki × B. papyrifera

1 reference

Broussonetia papyrifera

1 reference

Broussonetine C

1 reference

Broussonetine E

1 reference

Broussonetinine A

1 reference

(13S)-13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

1 reference

Broussonetine D

1 reference

1-hydroxy-13-[(2R,3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidin-2-yl]tridecan-4-one

1 reference

(13S)-13-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-5-one

1 reference

Broussonetine B

1 reference

1-Hydroxy-13-[4-hydroxy-5-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidin-2-yl]tridecan-5-one

1 reference

Broussonetinine B

1 reference

1 reference

Broussonetine F

1 reference

Broussonetine A

1 reference

author name string

M Shibano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Kitagawa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Nakamura

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N Akazawa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Kusano

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

0 references

publication date

1997

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/45/4/45_4_700/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.45.700?email=unpaywall_01@example.com

Chemical & Pharmaceutical Bulletin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

700-705

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.45.700?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Glycosylation inhibitors in biology and medicine

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.45.700

Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.45.700

Studies on the constituents of Cimicifuga species. XIX. Eight new glycosides from Cimicifuga simplex Wormsk

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.45.700

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.44.2078

Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.45.700

Identifiers

10.1248/CPB.45.700

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9145506%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73327949&oldid=2132617922"